We list occasional relevant media editorial regarding vaccines, DNA vaccines, and Inovio Pharmaceuticals.

Health: Local Researchers Developing MERS Virus Vaccine

In a TV interview,  Dr. Joseph Kim and Dr. David Weiner discuss the MERS virus and Inovio’s effort to create a potential DNA vaccine to combat this infectious disease.

CBS News
By Stephanie Stahl
May 2014

Watch Here

back to top

Taking Stock

In a radio interview, CEO Dr. Joseph Kim discusses the company’s attempt to develop a drug that trains the immune system to fight cancer.

Bloomberg Radio
By Pimm Fox and Carol Massar
February 2014

Listen Here

back to top

Start-up story: A 13-year pursuit of success

CEO Dr. Joseph Kim discusses his journey co-founding Inovio Pharmaceuticals.

USA Today
By Laura Baverman
January 2014

Full Article

back to top

Companies to Watch

Inovio is featured as the Company to Watch for its advancements in the field of DNA vaccines and immunotherapies.

Life Science Leader Magazine
By Wayne Koberstein
October 2013

Full Article

back to top

HIV Prevention Makes Strides

Dr. Joseph Kim discusses Inovio's approach to prevent and treat HIV infection.
 
PharmaVoice
October 2013
 
Full Article

back to top
 

Delivering a Cure for Hepatitis C Infection

Dr. Joseph Kim discusses Inovio's therapeutic HCV vaccine

Inovio Says H7N9 Bird Flu Vaccine Effective in Mice

Inovio's vaccine has shown promising results in preclinical studies against the virulent H7N9 avian influenza strain

Fierce Biotech Research
By Emily Mullin
June 2013

Full Article

back to top

Inovio's Chief Medical Officer Profiled in PULSE Magazine

The University of Medicine and Dentistry of New Jersey's PULSE Magazine
May 2013

Full Article

back to top

Philadelphia Business Journal 2013 40 Under 40

Ami Shah Brown, Sr. Director of Inovio’s Regulatory Affairs, was named one of the 40-Under-40 Most Promising Executives in the Philadelphia Region

Philadelphia Business Journal
April 2013

Full Article

back to top

H7N9 Vaccine At Least 6 Weeks Away

Dr. Joseph Kim discusses how quickly Inovio could create a DNA vaccine to protect against H7N9

U.S. News & World Report
By Jason Koebler
April 2013

Full Article

back to top

Chinese Government Suspects Human-to-Human Transmission of H7N9 Bird Flu

Inovio CEO Dr. Joseph Kim discusses the increase in H7N9 influenza cases

U.S. News & World Report
By Jason Koebler
April 2013

Full Article

back to top
 

George Mason University Hosts “From Bench to Bedside: DNA Vaccines”

Dr. Joseph Kim & Dr. David Weiner presented their views on biomedical translational research and global market

PWC
By Brent M. Heavner
March 2013

Full Article

back to top
 

Inovio CEO on DNA Vaccines

Dr. Joseph Kim shares his views on the future of DNA vaccines during an interview at The Wall Street Journal’s Unleashing Innovation conference in Singapore 

The Wall Street Journal
By Juro Osawa
February 2013

Full Article

back to top
 

How Drug Makers Think About Innovation

Dr. Joseph Kim of Inovio, Patrick Bergstedt of MSD, and Kiran Mazumda-Shaw of Biocon discuss innovation in medicine with the Wall Street Journal

The Wall Street Journal
By Geeta Anand
February 2013
 
Full Article

back to top
 
 

Why the Flu is So Relentless & How Technology Might Help

Researchers are developing quick-brew vaccines and ones that catch multiple strains of flu

MIT Technology Review
By Susan Young
January 28, 2013

Full Article 

back to top
 

Tackling Transfection Tasks

Genetic Engineering & Biotechnology News
By Neil Mckenna, Ph.D.
January 2013
 
Full Article

back to top  
 

University of Pennsylvania & Inovio Test Possible HIV Vaccine

6 ABC Action News
December 2012

Watch Video

back to top 
 

Study Looks at Vaccine to Treat HPV Infection

Times Dispatch
By Tammie Smith
December 2012

Full Article 

back to top 

Company Works to Develop 'Game Changing' HIV Vaccine

Fox 5 Sandiego
By Erica Fox
November 2012

Full Article

back to top

10 Promising Therapeutic Vaccines 2012

Fierce Vaccines
By Suzanne Elvidge
October 2012

Full Article

back to top

The Compelling Need for Game-Changing Influenza Vaccines

An Analysis of the Influenza Vaccine Enterprise and Recommendations for the Future

Center for Infectious Disease Research & Policy
By Michael T. Osterholm, et al.
October 2012

Full Article

back to top

New Vaccine Could Help Women Who Already Have HPV

My Health News Daily
By Rachael Rettner
October 2012

Full Article

back to top

Cervical Cancer Vaccine Shows Promise

Philly.com
By Sandy Bauers
October 2012

Full Article

back to top

Therapeutic Vaccine Shows Potential in Fighting Cervical Cancer

The New York Times
By Roni Caryn Rabin
October 2012

Full Article

back to top

Cervical Cancer Vaccine in Early Stages

CNN Health
By Elizabeth Landau
October 2012

Full Article

back to top

Electroporation Delivery of DNA Vaccines: Prospects for Success

PMC
By Niranjan Y. Sardesai & David B. Weiner
June 2012

Full Article

back to top

Inovio: A Rising Star in the World of Vaccines

eCliniqua
By Deborah Borfitz
September 2011

Full article

back to top


Dermal Electroporation: An Efficient and Tolerable Method of Delivering DNA Vaccines

This article describes the recent advances in dermal electroporation (ID ED) as an efficient platform for the delivery of DNA vaccines. In the future, dermal electroporation devices currently in development could offer an easy-to-use, tolerable, and low-cost strategy for mass immunizations with gene-based vaccines.

Transdermal
By Kate Broderick & Stephen Kemmerrer
January 2011

Article for purchase

back to top


DNA Drugs Come of Age

After years of false starts, a new generation of vaccines and medicines for HIV, influenza and other stubborn illnesses is now in clinical trials.

Scientific American
By Matthew P. Morrow & David B. Weiner
June 2010

Article for purchase

back to top